JDK Announces Breakthrough in the Development of Cefotaxime Sodium Pharmaceutical Intermediate [JDK] is proud to announce a major breakthrough in the development of pharmaceutical intermediates with

JDK, a company with a professional team equipped with specialized and interdisciplinary technical talents, has been making waves in the pharmaceutical industry with their latest product, ODM Astragalu

JDK, a company with a professional team equipped with specialized and interdisciplinary technical talents, has recently announced a groundbreaking development in the field of pharmaceutical intermedia

JDK, a leading company in the chemical industry, has recently made significant advancements in the development of pharmaceutical intermediates and basic chemicals. The company's professional team, equ

JDK, a company with a professional team equipped with specialized and interdisciplinary technical talents, has been focusing on the development of pharmaceutical intermediates and basic chemicals. The

China L-Tryptophan 60% Feed Grade: A Breakthrough in Animal Nutrition In the world of animal nutrition, the search for effective and high-quality feed additives is never-ending. Livestock and poultry

JDK, a company specializing in the development of pharmaceutical intermediates and basic chemicals, has announced the successful development of a new compound with the Cas No. 877399-00-3. This recent

JDK, a company with a professional team equipped with specialized and interdisciplinary technical talents, has been making waves in the pharmaceutical industry with its latest breakthrough in the deve

Levulinic Acid: A Sustainable Solution for Pharmaceuticals and Basic Chemicals In today's rapidly evolving world, the demand for sustainable and environmentally friendly solutions in the pharmaceutic

JDK, a leading company in the pharmaceutical industry, has recently announced that its Qibanqing Granules have received CE certification. This certification is a significant milestone for the company,